高尔基体
生物
雄激素受体
前列腺癌
癌症研究
细胞生物学
转录组
雄激素
内质网
癌症
内分泌学
基因
基因表达
遗传学
激素
作者
Lingling Hu,Xin Chen,Nitin Narwade,Michelle Gek Liang Lim,Zikai Chen,Chandana Tennakoon,Peiyong Guan,Un In Chan,Zhenqun Zhao,Mokan Deng,Xiaoling Xu,Wing‐Kin Sung,Edwin Cheung
出处
期刊:Oncogene
[Springer Nature]
日期:2021-10-05
卷期号:40 (47): 6479-6493
被引量:10
标识
DOI:10.1038/s41388-021-02026-7
摘要
Androgen receptor (AR) plays a central role in driving prostate cancer (PCa) progression. How AR promotes this process is still not completely clear. Herein, we used single-cell transcriptome analysis to reconstruct the transcriptional network of AR in PCa. Our work shows AR directly regulates a set of signature genes in the ER-to-Golgi protein vesicle-mediated transport pathway. The expression of these genes is required for maximum androgen-dependent ER-to-Golgi trafficking, cell growth, and survival. Our analyses also reveal the signature genes are associated with PCa progression and prognosis. Moreover, we find inhibition of the ER-to-Golgi transport process with a small molecule enhanced antiandrogen-mediated tumor suppression of hormone-sensitive and insensitive PCa. Finally, we demonstrate AR collaborates with CREB3L2 in mediating ER-to-Golgi trafficking in PCa. In summary, our findings uncover a critical role for dysregulation of ER-to-Golgi trafficking expression and function in PCa progression, provide detailed mechanistic insights for how AR tightly controls this process, and highlight the prospect of targeting the ER-to-Golgi pathway as a therapeutic strategy for advanced PCa.
科研通智能强力驱动
Strongly Powered by AbleSci AI